Cardiovascular Study / United Kingdom / £70 / Ends April 3rd (1)
We currently have a study on Cardiovascular Disease in the UK, where people who live with this condition, and their caregivers, can evaluate the safety and effectiveness of a pen-injector.
Time & Location
01 Apr 2023, 12:00 BST – 02 Apr 2023, 12:00 BST
60 min face to face London, 5th floor, 9 Kingsway, London WC2B 6XF, UK
Study objectives
The purpose of this research is to evaluate the safety and effectiveness of the DV3430 pen-injector and the applicable Instructions for Use (IFU).
The research is not designed to be promotional in any way. You have a right to withdraw from the interview at any time and withhold information as you see fit. All information provided will be treated in the strictest confidence and all data will only be reported in a consolidated form – no personal information (including your name, email address and phone number) will be included in any reports provided to the independent research organisation or the pharmaceutical company sponsoring the research.
The research will comply with the UK Data Protection Act, GDPR and with the British Healthcare Business Intelligence Association’s (BHBIA) Legal & Ethical Guidelines.
We will be conducting a 60-minute In-depth Interview (IDI) at a central location in London, and for your contribution you will be offered remuneration of £70.
With your permission, the interview will be video recorded, and the video streamed. The video recordings will also be shared with the pharmaceutical company for analysis purposes only.
